---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-23-043963"
form_type: "8-K/A"
ticker: "HRMY"
cik: "0001802665"
company_name: "Harmony Biosciences Holdings, Inc."
filed_at: "2023-09-14T23:59:59+00:00"
generated_at: "2026-06-10T17:45:18.156352+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.12
calibrated_materiality_score: 0.12
confidence: "high"
source: SEC EDGAR
---

# Harmony Biosciences corrects Zynerba merger agreement filing, removes non-binding disclaimer

## Summary
- Filed Amendment No. 1 to 8-K to correct Merger Agreement cover page that erroneously stated it was not binding.
- Corrected agreement is identical to August 14 version except for removal of the disclaimer.
- Merger consideration unchanged: $1.1059 per share cash plus one contingent value right per Zynerba share.
- No financial or operational changes; correction is procedural and does not alter the transaction terms.

## SEC filing metadata
- accession: 0001140361-23-043963
- form_type: 8-K/A
- ticker: HRMY
- cik: 0001802665
- company_name: Harmony Biosciences Holdings, Inc.
- filed_at: 2023-09-14T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.12
- calibrated_materiality_score: 0.12
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1802665/000114036123043963/0001140361-23-043963-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1802665/000114036123043963/ef20010653_8ka.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-23-043963
- JSON: https://secwatch.observer/filing/0001140361-23-043963.json
- Plain text: https://secwatch.observer/filing/0001140361-23-043963.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.